UPDATE: Intersect ENT (XENT) Posts Q2 Loss of $2.36/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. CVS
10. SPY

Go back to UPDATE: Intersect ENT (XENT) Posts Q2 Loss of $2.36/Share

Intersect ENT Reports Second Quarter 2014 Results

September 3, 2014 4:01 PM EDT

MENLO PARK, Calif., Sept. 3, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the second quarter of 2014.

Recent Accomplishments

Achieved Q2 revenue of $8.6 million, an increase of 118% over the second quarter of 2013   Realized gross margin of 73%, an increase of 66% from 44% in the second quarter of the prior year   Completed an initial public offering, raising $63.3M in gross proceeds   Completed the RESOLVE clinical study... More